Facebook
Twitter
LinkedIn
Forward
2nd Annual Conference on Psychedelics and Psychedelic Medicine
We invite you to join us at the Westin Copley place in Boston for our 2nd Annual Conference on Psychedelics and Psychedelic Medicine conference.
This conference will provide up-to-date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice. Mechanisms of action including pharmacology, neuroscience, psychodynamic theory will be discussed, with a focus on specific clinical entities such as depression, PTSD, and addictions. Additional panel discussions and presentations will explore history, ethics, cultural issues, plant medicine, and many other relevant topics within the rapidly growing field of psychedelic medicine.
Pricing
MDs/Doctoral-Level Professionals
Early Bird Registration (on or before October 7, 2022) $650.00
Regular Registration (after October 7, 2022) $675.00
Other Professionals or Trainees
Early Bird Registration (on or before October 7, 2022) $575.00
Regular Registration (after October 7, 2022) $620.00
Residents & Medical Students: $150.00
***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.
*New* Virtual Registration
We are now adding a full virtual option to accommodate those who can not attend in person. Full more information and to register, please click the link below.
Psychedelics 2022: Virtual Registration: Click HERE
E-SYLLABUS
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Cancellation Policy
A refund minus a $100.00 administrative fee will be issued for refund requests received by October 3, 2022. No refunds will be issued for refund requests made after October 3, 2022. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Target Audience
This program is intended for mental health practitioners including psychiatrists, psychiatric nurse practitioners, social workers and clinical psychologists.
Learning Objectives
By the end of this program, participants will be able to:
- Compare different models of psychedelic-assisted psychotherapy (eg, psycholytic vs psychedelic)
- Explain the neuropsychopharmacology of classical psychedelics as well as atypical psychedelics such as ketamine and empathogens such as MDMA
- Identify hypotheses for mechanisms of action of psychedelics on the brain, based on recent neuroimaging studies
- Critique contemporary medico-cultural issues within psychedelic research, including race-based structural biases and epistemic injustice
- Assess potential applications of psychedelic-assisted therapy in extra-psychiatric fields, such as within palliative care and spirituality, as well as within medicine, such as for pain and immunomodulation
Program Agenda
November 4-5, 2022
Day 1 – November 4, 2022
8:00-8:05 AM Welcome and Introduction
Franklin King, MD
8:05 – 8:25 AM A Brief History of Psychedelics
Franklin King, MD
8:25-8:45 AM Pharmacology
Franklin King, MD
8:45-9:30 AM Keynote: Psychedelic-Assisted Therapy: a 21st Century Approach to Mental Health?
Rick Doblin, PhD
9:30-9:45 AM Question & Answer
Moderator: Franklin King, MD
Discussant: Rick Doblin, PhD
9:45-10:00 AM Coffee Break
10:00-10:25 AM Psychedelics and Addictions
Brian Barnett, MD
10:25-10:50 AM Psychedelic-Assisted Psychotherapy and Depression
Sandeep Nayak, MD
10:50-11:15 AM MDMA-Assisted Therapy for PTSD
Anne Wagner, PhD
11:15-11:45 AM Panel Discussion
Moderator: Franklin King, MD
Panelists: Brian Barnett, MD, Sandeep Nayak, MD, Anne Wagner, PhD
11:45-12:45 PM Lunch Break (on your own)
12:45-1:15 PM Using Cognitive Neuroscience To Advance Treatment with Psychedelics
Sharmin Ghaznavi, MD, PhD
1:15-1:45 PM Pharmacological Neuroimaging with Psychedelics to Inform Individualized Treatment Selection in Psychiatric Disorders
Jie Lisa Ji, PhD
1:45-2:15 PM Panel Discussion
Moderator – Bruce Rosen, MD, PhD
Panelists: Sharmin Ghaznavi, MD, PhD, Jie Lisa Ji, PhD
2:15-2:30 PM Coffee Break
2:30-2:50 PM Challenges in Trial Design for Psychedelic-Assisted Therapies
Jordan Sloshower, MD
2:50-3:10 PM Risks of Psychedelics and Psychedelic Assisted Therapies
Alden Doerner Rinaldi, MD
3:10-3:40 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Jordan Sloshower, MD, Alden Doerner Rinaldi, MD
3:40-4:05 PM Ketamine and Esketamine for Major Depression
Cristina Cusin, MD
4:05-4:25 PM Ketamine-Assisted Psychotherapy – Inpatient Treatment of the Future?
Fernando Espi Forcen, MD
4:25-4:55 PM Building an Outpatient Practice for Ketamine-Assisted Psychotherapy
Maren Nyer, PhD, Albert Yeung, MD
4:55-5:25 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Cristina Cusin, MD, Fernando Espi MD, Maren Nyer PhD, Albert Yeung MD
5:25 PM Adjourn
Day 2 – November 5, 2022
8:00-8:05 AM Welcome & Introduction
Franklin King, MD
8:05-8:35 AM Psychedelic-Assisted Psychotherapy
Elizabeth Call, PhD
8:35-9:05 AM Psychodynamics in Psychedelic-Assisted Psychotherapy
Michael Alpert, MD
9:05-9:35 AM Panel Discussion
Moderator: Franklin King, MD
Panelists: Elizabeth Call, PhD, Michael Alpert, MD
9:35-9:50 AM Coffee Break
9:50-10:20 AM Challenging Structural Racism in Psychedelic Research
Darron Smith, PhD
10:20-10:50 AM Education and Training in Psychedelic-Assisted Therapies
Janis Phelps, PhD
10:50-11:20 AM Ethical and Epistemic Challenges in Psychedelic Therapy and Research
Eduardo Schenberg, PhD
11:20-11:50 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Darron Smith, PhD, Janis Phelps, PhD, Eduardo Schenberg, PhD
11:50-12:50 PM Lunch Break (on your own)
12:50-1:35 PM Psychedelic-Assisted Therapies in End-of-Life Care
Roxanne Sholevar, MD, Yvan Beaussant, MD, Zachary Sager, MD
1:35-2:05 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Roxanne Sholevar, MD, Yvan Beaussant, MD, Zachary Sager, MD
2:05-2:20 PM Coffee Break
2:20-2:50 PM Psychedelics and Spirituality
Michael Ferguson, PhD
2:50-3:20 PM The Neurobiology of Plant Medicine: What Tradition Can Teach Us About Personalized Medicine
Stephen Haggarty, PhD
3:20-3:50 PM Panel Discussion
Moderator: Franklin King, MD
Discussant: Michael Ferguson, PhD, Stephen Haggarty, PhD
3:50-4:15 PM Potential Medical Applications of Psychedelics: Psychedelics and Inflammation
Jeremy Ruskin, MD
4:15-4:40 PM Novel Research Approaches for Psychedelics and Pain Disorders
Arvina Grahl, PhD
4:40-5:10 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Jeremy Ruskin, MD, Arvina Grahl, PhD
5:10 PM Adjourn
Join us at the Westin Copley Place for the 2nd Annual Conference on Psychedelics and Psychedelic Medicine
We have arranged a special discounted rate for our valued attendees.
Please book by October 3, 2022 to enjoy this group rate.
We have arranged a special discounted rate for our valued Psychedelics 2022 attendees. Please note, discount hotel room reservations can only be honored for those that register for the course. Rooms booked without an accompanying MGH (Massachusetts General Hospital) course registration are subject to cancellation.
COURSE DIRECTOR:
Franklin King, MD
PLANNERS:
Franklin King, MD
Jane Pimental, MPH
David Rubin, MD
Susan Sprich, PhD
SPEAKERS:
Michael Alpert, MD
Brian Barnett, MD
Yvan Beaussant, MD
Elizabeth Call, PhD
Cristina Cusin, MD
Rick Doblin, PhD
Alden Doerner Rinaldi, MD
Fernando Espi Forcen, MD
Michael Ferguson, PhD
Sharmin Ghaznavi, MD, PhD
Arvina Grahl, PhD
Stephen Haggarty, PhD
Franklin King, MD
Jie Lisa Ji, PhD
Sandeep Nayak, MD
Maren Nyer, PhD
Janis Phelps, PhD
Bruce Rosen, MD, PhD
Jerrold Rosenbaum, MD
Jeremy Ruskin, MD
Zachary Sager, MD
Eduardo Schenberg, PhD
Roxanne Sholevar, MD
Jordan Sloshower, MD
Darron Smith, PhD
Anne Wagner, PhD
Rachel Yehuda, PhD
Albert Yeung, MD
Available Credit
- 15.25 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 15.25 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 15.25 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 15.25 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 15.00 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 15.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 91320
- 15.25 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 15.25 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 15.25 Continuing Education (CE) credits per presentation for psychologists.
Price
Planners
David H. Rubin, MD, reviewer
Jane Pimental, MPH
Susan E. Sprich, PhD, psychologist reviewer
Franklin King, MD
Disclosure Information
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all relevant financial relationships with commercial interests of both themselves and their spouses/partners over the past 12 months, as defined below:
Ineligible Companies
The ACCME defines an "Ineligible company" as "those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients." For more information, visit accme.org/standards
Financial relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Mitigation of Financial Relationships
All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.
The following planners, speakers, content reviewers, and others in control of educational content have reported financial relationships with ineligible companies over the past 24 months. Measures have been taken to mitigate the impact of these financial relationships on the educational content and ensure that they do not insert commercial bias into the content of this education
Susan Sprich, PhD (Psychologist Reviewer)
Royalties (Co-Author): Oxford University Press
Royalties (Co-Edited Book): Springer
Honoraria (Associate Editors): Association for Behavioral and Cognitive Therapies (ABCT)
All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.
Hardware/Software Specifications
This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Minimum Requirements
Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit